These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 25089379)

  • 21. Cryptostatin, a chagasin-family cysteine protease inhibitor of Cryptosporidium parvum.
    Kang JM; Ju HL; Yu JR; Sohn WM; Na BK
    Parasitology; 2012 Jul; 139(8):1029-37. PubMed ID: 22444160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorine Scan of Inhibitors of the Cysteine Protease Human Cathepsin L: Dipolar and Quadrupolar Effects in the π-Stacking of Fluorinated Phenyl Rings on Peptide Amide Bonds.
    Giroud M; Harder M; Kuhn B; Haap W; Trapp N; Schweizer WB; Schirmeister T; Diederich F
    ChemMedChem; 2016 May; 11(10):1042-7. PubMed ID: 27095165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dipeptide-derived nitriles containing additional electrophilic sites: potentially irreversible inhibitors of cysteine proteases.
    Löser R; Gütschow M
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1245-52. PubMed ID: 19912058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
    Schirmeister T
    J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of novel cathepsin inhibitors with potent anti-metastatic effects in breast cancer cells.
    Yuan L; Sheng L; He W; Zou C; Hu B; Liu J; Ge W; Liu Y; Wang J; Ma E
    Bioorg Chem; 2018 Dec; 81():672-680. PubMed ID: 30253340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases.
    Pol E; Björk I
    Protein Sci; 2001 Sep; 10(9):1729-38. PubMed ID: 11514663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorobenzoyl dipeptidyl derivatives as inhibitors of the Fasciola hepatica cysteine protease cathepsin L1.
    Moran BW; Anderson FP; Ruth DM; Fágáin CO; Dalton JP; Kenny PT
    J Enzyme Inhib Med Chem; 2010 Feb; 25(1):1-12. PubMed ID: 20030504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cells.
    Shah PP; Wang T; Kaletsky RL; Myers MC; Purvis JE; Jing H; Huryn DM; Greenbaum DC; Smith AB; Bates P; Diamond SL
    Mol Pharmacol; 2010 Aug; 78(2):319-24. PubMed ID: 20466822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The propeptide of cruzipain--a potent selective inhibitor of the trypanosomal enzymes cruzipain and brucipain, and of the human enzyme cathepsin F.
    Reis FC; Costa TF; Sulea T; Mezzetti A; Scharfstein J; Brömme D; Ménard R; Lima AP
    FEBS J; 2007 Mar; 274(5):1224-34. PubMed ID: 17298440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New specific inhibitor design by computer-graphics of protease structure].
    Katunuma N
    Tanpakushitsu Kakusan Koso; 1997 Oct; 42(14 Suppl):2474-81. PubMed ID: 9366234
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization of cysteine proteases and their endogenous inhibitors in MCF-7 and adriamycin-resistant MCF-7 human breast cancer cells.
    Scaddan PB; Dufresne MJ
    Invasion Metastasis; 1993; 13(6):301-13. PubMed ID: 7860223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cathepsin L targeting in cancer treatment.
    Sudhan DR; Siemann DW
    Pharmacol Ther; 2015 Nov; 155():105-16. PubMed ID: 26299995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases.
    Carmona E; Dufour E; Plouffe C; Takebe S; Mason P; Mort JS; Ménard R
    Biochemistry; 1996 Jun; 35(25):8149-57. PubMed ID: 8679567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a potent and selective non-basic cathepsin K inhibitor.
    Li CS; Deschenes D; Desmarais S; Falgueyret JP; Gauthier JY; Kimmel DB; Léger S; Massé F; McGrath ME; McKay DJ; Percival MD; Riendeau D; Rodan SB; Thérien M; Truong VL; Wesolowski G; Zamboni R; Black WC
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1985-9. PubMed ID: 16413777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3,4-disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P3 elements for potency and selectivity.
    Setti EL; Davis D; Janc JW; Jeffery DA; Cheung H; Yu W
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1529-34. PubMed ID: 15713422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The identification, characterization and optimization of small molecule probes of cysteine proteases: experiences of the Penn Center for Molecular Discovery with cathepsin B and cathepsin L.
    Huryn DM; Smith AB
    Curr Top Med Chem; 2009; 9(13):1206-16. PubMed ID: 19807666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine proteinase inhibitors.
    Bervar A; Zajc I; Sever N; Katunuma N; Sloane BF; Lah TT
    Biol Chem; 2003 Mar; 384(3):447-55. PubMed ID: 12715895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
    Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL
    J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents.
    Kim SH; Lee E; Baek KH; Kwon HB; Woo H; Lee ES; Kwon Y; Na Y
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3320-4. PubMed ID: 23608763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The marine cyanobacterial metabolite gallinamide A is a potent and selective inhibitor of human cathepsin L.
    Miller B; Friedman AJ; Choi H; Hogan J; McCammon JA; Hook V; Gerwick WH
    J Nat Prod; 2014 Jan; 77(1):92-9. PubMed ID: 24364476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.